Found: 221
Select item for more details and to access through your institution.
Mitoxantrone and abacavir: An ALK protein-targeted in silico proposal for the treatment of non-small cell lung cancer.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0295966
- By:
- Publication type:
- Article
Abacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight Bands.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 11, p. 574, doi. 10.1093/jpids/piad082
- By:
- Publication type:
- Article
Correction to: efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1.
- Published in:
- Infection & Chemotherapy, 2023, v. 55, n. 3, p. 337, doi. 10.3947/ic.2022.0176
- By:
- Publication type:
- Article
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2315, doi. 10.1093/jac/dkad237
- By:
- Publication type:
- Article
Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 8, p. 2117, doi. 10.1007/s40121-023-00848-4
- By:
- Publication type:
- Article
Increased human immunodeficiency virus viral load with cerebral infarction due to varicella zoster virus vasculopathy on treatment with bictegravir/emtricitabine/tenofovir alafenamide suspension: a case report and literature review.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-023-00547-7
- By:
- Publication type:
- Article
SYNTHESIS, MOLECULAR DOCKING, IN-SILICO ADMET SCREENING, STRUCTURAL SAFETY EVALUATION OF ABACAVIR SULFATE AND ITS NOVEL MODIFIED SUBSTANCE.
- Published in:
- Rasayan Journal of Chemistry, 2023, v. 16, n. 3, p. 1137, doi. 10.31788/RJC.2023.1638335
- By:
- Publication type:
- Article
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1628, doi. 10.1093/cid/ciac972
- By:
- Publication type:
- Article
Effect of Food on the Pediatric Dispersible Tablet Formulations of TRIUMEQ and DOVATO in Healthy Adult Participants.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 5, p. 1470, doi. 10.3390/pharmaceutics15051470
- By:
- Publication type:
- Article
Abacavir use is associated with increased prothrombin conversion.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1182942
- By:
- Publication type:
- Article
Comparison between the impact of tenofovir alafenamide and that of abacavir on rapid kidney function decline: A retrospective observational study.
- Published in:
- HIV Medicine, 2023, v. 24, n. 4, p. 422, doi. 10.1111/hiv.13408
- By:
- Publication type:
- Article
Chemometrics Assisted Spectrophotometric Method Development and Validation for Simultaneous Estimation of Abacavir, Lamivudine and Dolutegravir in Dosage Form.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, n. 2, p. 570, doi. 10.5530/ijper.57.2.70
- By:
- Publication type:
- Article
Comparison of Chemical and Electrochemical Approaches to Abacavir Oxidative Stability Testing.
- Published in:
- Sensors (14248220), 2023, v. 23, n. 5, p. 2776, doi. 10.3390/s23052776
- By:
- Publication type:
- Article
AOP-Based Transformation of Abacavir in Different Environments: Evolution Profile of Descyclopropyl-Abacavir and In Silico Toxicity Assessment of the Main Transformation Products.
- Published in:
- Molecules, 2023, v. 28, n. 4, p. 1866, doi. 10.3390/molecules28041866
- By:
- Publication type:
- Article
BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022.
- Published in:
- HIV Medicine, 2022, v. 23, p. 3, doi. 10.1111/hiv.13446
- By:
- Publication type:
- Article
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286).
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 3267, doi. 10.2147/PPA.S379065
- By:
- Publication type:
- Article
Severe abacavir hypersensitivity reaction in a patient with human immunodeficiency virus infection: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
LONG-TERM INTEGRATED ANALYSIS OF B/F/TAF IN TREATMENT-NAÏVE ADULTS WITH HIV THROUGH FIVE YEARS OF FOLLOW-UP.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 283
- By:
- Publication type:
- Article
Toxicity estimation using QSAR methodology and analytical approach for the accurate determination of two potential genotoxic impurities in Abacavir Sulfate antiviral drug at TTC level by liquid chromatographymass spectrometry (LC-MS/MS).
- Published in:
- Journal of Pharmaceutical Negative Results, 2022, v. 13, p. 1939, doi. 10.47750/pnr.2022.13.S01.230
- By:
- Publication type:
- Article
Pharmacokinetic Study of Abacavir Sulphate Loaded Niosomes and Proniosomes in Rats.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2022, v. 84, n. 5, p. 1189, doi. 10.36468/pharmaceutical-sciences.1013
- By:
- Publication type:
- Article
Summaries of safety labeling changes approved by FDA—Boxed warnings highlights, January–March 2022.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 13, p. 1036, doi. 10.1093/ajhp/zxac148
- Publication type:
- Article
Summaries of safety labeling changes approved by FDA—Boxed warnings highlights, January–March 2022.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 13, p. e155, doi. 10.1093/ajhp/zxac149
- Publication type:
- Article
NOVEL SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ABACAVIR SULPHATE, LAMIVUDINE AND DOLUTEGRAVIR SODIUM IN DOSAGE FORM.
- Published in:
- Indian Drugs, 2022, v. 59, n. 7, p. 44, doi. 10.53879/id.59.07.12415
- By:
- Publication type:
- Article
Effectiveness, Durability, and Safety of Dolutegravir and Lamivudine Versus Dolutegravir, Lamivudine, and Abacavir in a Real-Life Cohort of HIV-Infected Adults.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 4, p. 412, doi. 10.1177/10600280211034176
- By:
- Publication type:
- Article
Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3815, doi. 10.3390/ijms23073815
- By:
- Publication type:
- Article
Abacavir antiretroviral therapy and indices of subclinical vascular disease in persons with HIV.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0264445
- By:
- Publication type:
- Article
Proteomic Profiling and T Cell Receptor Usage of Abacavir Susceptible Subjects.
- Published in:
- Biomedicines, 2022, v. 10, n. 3, p. 693, doi. 10.3390/biomedicines10030693
- By:
- Publication type:
- Article
Simultaneous Occurrence of Nephrolithiasis, Fanconi Syndrome, and Nephro-osteopathy in a Patient on First-line Antiretroviral Therapy -- A Case Report.
- Published in:
- Indian Journal of Nephrology, 2022, v. 32, n. 2, p. 175, doi. 10.4103/ijn.IJN_456_20
- By:
- Publication type:
- Article
Virological outcomes with dolutegravir plus either lamivudine or two NRTIs as switch strategies: a multi-cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Photo-induced electron transfer of [C<sub>60</sub> + Abacavir] nano-complex and feasibility of C<sub>60</sub> fullerene application as a chemical shift reagent: a DFT/TD-DFT insights.
- Published in:
- Journal of the Iranian Chemical Society, 2022, v. 19, n. 3, p. 937, doi. 10.1007/s13738-021-02360-3
- By:
- Publication type:
- Article
Pharmacokinetic Outcomes of the Interactions of Antiretroviral Agents with Food and Supplements: A Systematic Review and Meta-Analysis.
- Published in:
- Nutrients, 2022, v. 14, n. 3, p. 520, doi. 10.3390/nu14030520
- By:
- Publication type:
- Article
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 3, p. 1, doi. 10.1093/ofid/ofab595
- By:
- Publication type:
- Article
Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03058-9
- By:
- Publication type:
- Article
Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medications.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 2, p. 403, doi. 10.1111/bcp.14984
- By:
- Publication type:
- Article
Unravelling the Proteomics of HLA-B*57:01 + Antigen Presenting Cells during Abacavir Medication.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 1, p. 40, doi. 10.3390/jpm12010040
- By:
- Publication type:
- Article
Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 1, p. 8, doi. 10.3390/ph15010008
- By:
- Publication type:
- Article
Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS).
- Published in:
- AIDS Research & Therapy, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12981-021-00402-7
- By:
- Publication type:
- Article
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 8, p. 1440, doi. 10.1093/cid/ciab444
- By:
- Publication type:
- Article
Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.722204
- By:
- Publication type:
- Article
Prevalence of Abacavir Hypersensitivity Reaction and Cost-Effectiveness of HLA-B*5701 Screening: A Ten-Year Experience in The HRH Princess Maha Chakri Sirindhorn Medical Center.
- Published in:
- Journal of the Medical Association of Thailand, 2021, v. 104, n. 10, p. 1698, doi. 10.35755/jmedassocthai.2021.10.13128
- By:
- Publication type:
- Article
DEVELOPMENT AND VALIDATION OF A NEW HPLC BIOANALYTICAL INTERNAL STANDARD METHOD FOR THE ANALYSIS OF REMDESIVIRIN HUMAN PLASMA.
- Published in:
- Rasayan Journal of Chemistry, 2021, v. 14, n. 4, p. 2639, doi. 10.31788/RJC.2021.1446373
- By:
- Publication type:
- Article
Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States.
- Published in:
- AIDS Research & Therapy, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12981-021-00383-7
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 985, doi. 10.1002/cpdd.996
- By:
- Publication type:
- Article
Weight‐adapted fixed‐dose combined adult antiretroviral tablets for HIV‐infected children.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 4, p. 867, doi. 10.1111/jcpt.13341
- By:
- Publication type:
- Article
Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.
- Published in:
- BMC Immunology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12865-021-00427-7
- By:
- Publication type:
- Article
Development and validation of a sensitive bioanalytical method for the estimation of anti-viral drugs by lc-ms/ms method.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 3, p. 482, doi. 10.31838/ijpr/2021.13.03.36
- By:
- Publication type:
- Article
Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single‐tablet regimen in a multicentre cohort in Spain.
- Published in:
- Journal of the International AIDS Society, 2021, v. 24, n. 7, p. 1, doi. 10.1002/jia2.25758
- By:
- Publication type:
- Article
Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV).
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. 2032, doi. 10.1093/cid/ciaa1026
- By:
- Publication type:
- Article
Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.672737
- By:
- Publication type:
- Article